维普中文期刊产品整合服务
254篇 您的检索式:作者名="Eiermann"
    题名 作者 年代 出处 被引量
1Immunodominance and functional alterations of tumor‐associated antigen‐specific CD8+ T‐cell responses in hepatocellular carcinoma显示文摘Tobias Flecken Nathalie Schmidt Sandra Hild Emma Gostick Oliver Drognitz Robert Zeiser Peter Schemmer Helge Bruns Thomas Eiermann David A. Price Hubert E. Blum Christoph Neumann‐Haefelin Robert Thimme 2014Hepatology2014,,:2
2An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane显示文摘Buzdar AU Robertson JF Eiermann W 2002Cancer2002,95,9:1
3Phase m study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial显示文摘Eiermann W Pienkowski T Crown J 2011J Clin Oncol2011,29,:1
4Neoadjuvantand adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with aparallel HER2-negative cohort显示文摘Gianni L Eiermann W Semiglazov V eral 2014Lancet Oncol2014,15,6:1
5Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study显示文摘W. Eiermann S. Paepke J. Appfelstaedt A. Llombart-Cussac J. Eremin J. Vinholes L. Mauriac M. Ellis M. Lassus H. A. Chaudri-Ross M. Dugan M. Borgs V. Semiglazov 2001Annals of Oncology2001,,11:1
6Neoadjuvant and adjuvant trastuzumab in patients with HER-2-positive locally ad- vanced breast cancer (NOAH) : follow-up of a randomised con- trolled superiority trial with a parallel HER-2-negative cohort显示文摘Gianni L Eiermann W Semiglazov V 2014Lancet Oncol2014,15,6:1
7Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes显示文摘Mu J Petrov A Eiermann GJ 2009Eur I Pharmacol2009,623,13:1
8Phase Ⅲ randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (AC→T) with doxorubicin and cyclophosphamide followed by docetax- el and trastuzumab (AC→TH) with docetaxel, carboplatin and trastu- zumab(TCH) in HER2 positive early breast cancer patients: BCIRG 006 study显示文摘Slamon D Eiermann W Robert N 2006Breast Cancer Res Treat2006,100,1:1
9Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes 显示文摘Mu J Petrov A Eiermann G J 2009European Journal of Pharmacology2009,623,123:1
10Preoperative treatment of postmenopausal breast cancer patients with letro- zole: a randomized double-blind muhicenter study显示文摘Eiermann W Paepke S Appfelstaedt J 2001Ann Oncol2001,12,11:1
11Adjuvant trastuzumab in HER2-positive breast cancer 显示文摘Simon D Eiermann W Robert N 2011N EngI J Med2011,365,14:1
12tumor necrosis factoralpha gene polymorphism in psoriasis 显示文摘Arias AI Giles B Eiermann TH 1997Exp Clin Immunogenet1997,14,2:1
13Preoperative treatment of postmenopausal breast cancer patients with letrozole : a randomized double- blind multicenter study 显示文摘Eiermann W Paepke S Appfelstaedt L 2001Ann Oncol2001,12,11:1
14Adjuvant trastuzumab in HER2-Positive breast cancer显示文摘Slamon D Eiermann W Robert N 2011N Engl J Med2011,365,14:1
15A phase Ⅲ randomized trial comparing docetaxel in combination with doxorubiein and cyclophosphamide (TAC) versus doxorubicin and cyclophosphamide followed by docetaxel (ACT) in women with Her 2/neu negative axillary lymph node positive early breast cancer显示文摘Eiermann W Pienkowski T Crown J 2009Cancer Res2009,77,:1
16Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer 显示文摘GIANNI L BASELGA J EIERMANN W 2009J Clin Oneol2009,27,15:1
17Adjuvant trastuzumab in HER-2-posidve breast cancer显示文摘Slamon D Eiermann W Robert N 2011N Engl J Med2011,365,14:1
18Acceleration of relaxation methods for non-Hermitian linear systems 显示文摘Eiermann M Niethammer W Varga R S 1992Siam J Matrix Anal1992,13,3:1
19BCIRG 005 main efficacy analysis: a phase Ⅲ randomized trial comparing do cetaxel in combination with doxorubicin and cyclophosphamide (TAC) versus doxorubiein and eyelophosphamlde followed by docetaxel (ACT) in women with Her-2/neu negative axillary lymph node positive early breast cancer 显示文摘Eiermann W Pienkowski T Crown J 2009Cancer Res2009,6977,:1
20Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone,in patients with HER2-positive locally advanced breast cancer(the NOAH trial):a randomised controlled superiority trial with a parallel HER2-negative cohort显示文摘Gianni L Eiermann W Semiglazov V 2010Lancet2010,375,9712:1
返回顶部 每页显示:
共13页 首页 上一页 第1页 下一页 末页 /13 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费